Analyzing Homologous Recombination at a Genome-Wide Level

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• DNA double-strand breaks (DSBs) are highly toxic DNA lesions arising from endogenous and exogenous sources.
• Defects in DSB repair pathways, including homologous recombination (HR) and nonhomologous end joining (NHEJ), are linked to various human diseases.
• The choice between HR and NHEJ depends on factors like cell cycle stage, lesion complexity, and genomic location.

Purpose of the Study:

• To develop and validate a genome-wide method for studying the usage of the HR machinery at DSBs.
• To investigate the factors influencing the selection of HR for DSB repair.

Main Methods:

• Genome-wide chromatin immunoprecipitation (ChIP) targeting the HR core component Rad51.
• High-throughput sequencing (HTS) to analyze Rad51 binding sites across the genome.
• Integration of ChIP-seq data with other genomic and cell cycle information.

Main Results:

• The developed ChIP-seq method successfully maps Rad51 recruitment to DSBs genome-wide.
• The study provides insights into the distribution and regulation of HR activity across the genome.
• Identification of genomic features and cellular conditions that favor HR-mediated repair.

Conclusions:

• The proposed genome-wide ChIP-seq approach is effective for studying HR pathway usage at DSBs.
• Understanding HR dynamics is crucial for comprehending genome stability and disease pathogenesis.
• This method can be applied to further investigate DNA repair mechanisms and their implications in health and disease.